{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:17:44Z","timestamp":1761621464896,"version":"build-2065373602"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.neulet.2019.134366","type":"journal-article","created":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T10:23:21Z","timestamp":1563618201000},"page":"134366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Targeting apolipoprotein E for treating Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"709","author":[{"given":"Kelly R.","family":"Bales","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2019","key":"10.1016\/j.neulet.2019.134366_bib0005","first-page":"321","article-title":"Alzheimer\u2019s disease facts and figures","volume":"15","author":"Alzheimer\u2019s Association","year":"2019","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.neulet.2019.134366_bib0010","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dosage of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.134366_bib0015","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/hmg\/3.4.569","article-title":"Apolipoprotein E, \u03b54 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer\u2019s disease: analysis of the 19q13.2 chromosomal region","volume":"3","author":"Harlin-Chartier","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neulet.2019.134366_bib0020","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neulet.2019.134366_bib0025","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neulet.2019.134366_bib0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer\u2019s disease : pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neulet.2019.134366_bib0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","article-title":"Cholesterol metabolism in the brain","volume":"12","author":"Dietschy","year":"2001","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.neulet.2019.134366_bib0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","article-title":"Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s disease","volume":"72","author":"Huang","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2019.134366_bib0045","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1074\/jbc.R800009200","article-title":"Understanding the association of apolipoprotein E4 with Alzheimer disease clues from its structure","volume":"284","author":"Zhong","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.134366_bib0050","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apoliporpotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.134366_bib0055","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.neulet.2019.134366_bib0060","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaneurol.2017.2188","article-title":"Apolipoprotein E genotype and sex risk factors for Alzheimer disease: a meta-analysis","volume":"74","author":"Neu","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neulet.2019.134366_bib0065","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ana.24135","article-title":"Sex modifies the APOE-related risk of developing Alzheimer\u2019s disease","author":"Altmann","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2019.134366_bib0070","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.biopsych.2013.06.003","article-title":"Genetics of Alzheimer\u2019s disease in Caribbean hispanic and African American populations","author":"Reitz","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2019.134366_bib0075","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0140-6736(93)91728-5","article-title":"Apolipoprotein e genotype and Alzheimer\u2019s disease","volume":"342","author":"Noguchi","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2019.134366_bib0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-neuro-071013-014300","article-title":"Apolipoprotein E in Alzheimer\u2019s disease: an update","volume":"37","author":"Yu","year":"2014","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neulet.2019.134366_bib0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ana.10636","article-title":"Apolipoprotein E \u03b54 modifies Alzheimer\u2019s disease onset in an E280A PS1 kindred","volume":"54","author":"Pastero","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2019.134366_bib0090","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neulet.2018.07.010","article-title":"Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer\u2019s disease","volume":"684","author":"Bratosiewicz-Wasik","year":"2018","journal-title":"Neurosci. Lett. Suppl."},{"key":"10.1016\/j.neulet.2019.134366_bib0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","article-title":"APOE \u03b54 increases risk for dementia in pure synucleopathies","volume":"70","author":"Tsuang","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neulet.2019.134366_bib0100","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","article-title":"TREM2 binds to apolipoproteins including APOE and CLU\/APOJ and thereby facilitates uptake of amyloid-beta by microglia","volume":"91","author":"Yeh","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.134366_bib0105","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: High-avidity binding to \u03b2-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2019.134366_bib0110","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid \u03b2 peptide: isoform-specific effects and implications for late-onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2019.134366_bib0115","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1073\/pnas.92.8.3586","article-title":"Quantitative analysis of senile plaques in Alzheimer\u2019s disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome)","volume":"92","author":"Hyman","year":"1995","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2019.134366_bib0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0304-3940(92)90444-C","article-title":"Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid","volume":"135","author":"Wisniewski","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2019.134366_bib0125","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1523\/JNEUROSCI.0887-09.2009","article-title":"Human APOE isoform-dependent effects on brain \u03b2-amyloid levels in PDAPP transgenic mice","volume":"29","author":"Bales","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134366_bib0130","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","article-title":"Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease","volume":"97","author":"Holtzman","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2019.134366_bib0135","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1523\/JNEUROSCI.5170-04.2005","article-title":"Human apolipoprotein E4 alters the amyloid-beta 40:42 ration and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model","volume":"25","author":"Fryer","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134366_bib0140","doi-asserted-by":"crossref","first-page":"15233","DOI":"10.1073\/pnas.96.26.15233","article-title":"Apolipoprotein E is essential for amyloid deposition in the APP (V717F) transgenic mouse model of Alzheimer\u2019s disease","volume":"96","author":"Bales","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2019.134366_bib0145","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.neurobiolaging.2015.04.001","article-title":"Changes in A\u03b2 biomarkers and associations with APOE genotype in 2 longitudinal cohorts","volume":"36","author":"Resnick","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2019.134366_bib0150","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1212\/WNL.0000000000004336","article-title":"Alzheimer\u2019s disease Neuroimaging initiative, APOE genotype and early \u03b2-amyloid accumulation in older adults without dementia","volume":"89","author":"Lim","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2019.134366_bib0155","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","author":"Morris","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2019.134366_bib0160","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1073\/pnas.0500579102","article-title":"Correlations between apolipoprotein E \u03b54 gene dose and brain-imaging measurements hypometabolism","volume":"102","author":"Reinman","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2019.134366_bib0165","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMoa0809437","article-title":"Longitudinal modeling of age-related memory decline and the APOE \u03b54 effect","volume":"361","author":"Caselli","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neulet.2019.134366_bib0170","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.1424","article-title":"Association of amyloid and tau with cognition in preclinical Alzheimer disease A longitudinal study","author":"Hanseeuw","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neulet.2019.134366_bib0175","first-page":"856","article-title":"Human amyloid-\u03b2 synthesis and clearance rates as measured in cerebrospinal fluid in vivo","volume":"12","author":"Bateman","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134366_bib0180","doi-asserted-by":"crossref","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.134366_bib0185","doi-asserted-by":"crossref","first-page":"27204","DOI":"10.1074\/jbc.M116.721779","article-title":"Human central nervous system (CNS) ApoE isoforms are increased by age, differentially altered by amyloidosis, and relative amounts reversed in the CNS compared with plasma","volume":"291","author":"Nigh-Baker","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.134366_bib0190","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci. Trans. Med."},{"key":"10.1016\/j.neulet.2019.134366_bib0195","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1172\/JCI36663","article-title":"apoE-isoform-specific disruption of amyoid \u03b2 peptide clearance from mouse brain","author":"Deane","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2019.134366_bib0200","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","article-title":"ApoE4 accelerates early seeding of amyloid pathology","volume":"96","author":"Liu","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.134366_bib0205","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ana.410380219","article-title":"Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy","volume":"38","author":"Greenberg","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2019.134366_bib0210","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1523\/JNEUROSCI.4337-04.2005","article-title":"Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta","volume":"25","author":"Racke","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134366_bib0215","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1124\/jpet.110.172932","article-title":"Magnetic resonance imaging detection and time course of cerebral microhemorrhages during passive immunotherapy in living amyloid precursor protein transgenic mice","volume":"335","author":"Luo","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2019.134366_bib0220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(12)70015-7","article-title":"Amyloid-related imaging abnormalities in patients with Alzheimer\u2019s disease treated with bapineuzumab: a retrospective analysis","volume":"11","author":"Sperling","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neulet.2019.134366_bib0225","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1212\/WNL.0b013e3181c67808","article-title":"A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease","volume":"73","author":"Salloway","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2019.134366_bib0230","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/exnr.1994.1019","article-title":"Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype","volume":"125","author":"Strittmatter","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2019.134366_bib0235","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1073\/pnas.91.23.11183","article-title":"Isoform-specific interactions of apolipoprotein E with microtubule associated protein tau: implications for Alzheimer disease","volume":"91","author":"Strittmater","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2019.134366_bib0240","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0306-4522(95)00331-C","article-title":"Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer\u2019s disease","volume":"69","author":"Nagy","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2019.134366_bib0245","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.134366_bib0250","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/awx066","article-title":"Gene-based association studies report genetic links for clinical subtypes of frontotemporal dementia","volume":"140","author":"Mishra","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2019.134366_bib0255","first-page":"241","article-title":"Apolipoprotein E in Alzheimer\u2019s disease and other neurological disorders","volume":"10","author":"Verghese","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2019.134366_bib0260","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau PET imaging in aging and early Alzheimer\u2019s disease","volume":"79","author":"Johnson","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2019.134366_bib0265","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.neurobiolaging.2009.05.011","article-title":"Reduced levels of human apoE4 protein in an animal model of cognitive impairment","volume":"32","author":"Sullivan","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2019.134366_bib0270","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neurobiolaging.2004.09.003","article-title":"Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer\u2019s disease","volume":"26","author":"Poirier","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2019.134366_bib0275","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1523\/JNEUROSCI.1972-08.2008","article-title":"Impact of apolipoprotein E (ApoE) polymorphism on brain apoE levels","volume":"28","author":"Riddell","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134366_bib0280","doi-asserted-by":"crossref","first-page":"50380","DOI":"10.1074\/jbc.M204898200","article-title":"Apolipoprotein E4 forms a molten globule","volume":"52","author":"Morrow","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.134366_bib0285","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1073\/pnas.151254698","article-title":"Apolipoprotein E fragments present in Alzheimer\u2019s disease brain induce neurofibrillary tangle-like intracellular inclusions in neurons","volume":"98","author":"Huang","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2019.134366_bib0290","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/JMN:23:3:189","article-title":"Diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer\u2019s disease brain","volume":"23","author":"Huang","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neulet.2019.134366_bib0295","doi-asserted-by":"crossref","first-page":"9473","DOI":"10.1021\/jacs.6b03463","article-title":"HtrA1 proteolysis of ApoE in vitro is allele selective","volume":"138","author":"Chu","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neulet.2019.134366_bib0300","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1073\/pnas.1018381108","article-title":"C-terminal-truncated apolipoprotein E (apoE) E4 inefficiently clears amyloid beta (A\u03b2) and acts in concert with A\u03b2 to elicit neuronal and behavioral deficits in mice","volume":"108","author":"Ly-Bien","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2019.134366_bib0305","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00401-010-0666-1","article-title":"Accumulation of intraneuronal A\u03b2 correlates with ApoE4 genotype","volume":"119","author":"Christensen","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neulet.2019.134366_bib0310","doi-asserted-by":"crossref","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","article-title":"Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid \u03b2 peptide","volume":"32","author":"Hashimoto","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134366_bib0315","doi-asserted-by":"crossref","first-page":"18787","DOI":"10.1073\/pnas.0604011103","article-title":"Blocking the apolipoprotein E\/amyloid-\u03b2\u202finteraction as a potential therapeutic approach for Alzheimer\u2019s disease","volume":"103","author":"Sadowski","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2019.134366_bib0320","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000334914","article-title":"APOE-mimetic peptides reduce behavioral deficits, plaques, and tangles in Alzheimer\u2019s disease transgenics","volume":"10","author":"Vitek","year":"2012","journal-title":"Neurodeg. Dis."},{"key":"10.1016\/j.neulet.2019.134366_bib0325","doi-asserted-by":"crossref","first-page":"46461","DOI":"10.1038\/srep46461","article-title":"Neuroprotective pentapeptide CN-105 is associated with reduced sterile inflammation and improved functional outcomes in a traumatic brain injury murine model","volume":"7","author":"Laskowitz","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neulet.2019.134366_bib0330","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1073\/pnas.0600549103","article-title":"Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer\u2019s disease","volume":"103","author":"Mahley","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2019.134366_bib0335","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1021\/jm3008618","article-title":"Small-molecule structure correctors target abnormal protein structures and function: structure corrector rescue of apolipoprotein E4-associated neuropathology","volume":"55","author":"Mahley","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neulet.2019.134366_bib0340","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.neulet.2019.134366_bib0345","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41577-018-0051-1","article-title":"Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight","volume":"18","author":"Shi","year":"2018","journal-title":"Nat. Rev. Immun."},{"key":"10.1016\/j.neulet.2019.134366_bib0350","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jaci.2014.01.032","article-title":"APO\u03b54 is associated with enhanced in vivo innate immune responses in human subjects","volume":"134","author":"Gale","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.neulet.2019.134366_bib0355","article-title":"Association of chronic low-grade inflammation with risk of Alzheimer disease in APOE4 carriers","volume":"1","author":"Tao","year":"2018","journal-title":"JAMA Network"},{"key":"10.1016\/j.neulet.2019.134366_bib0360","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1126\/science.7863332","article-title":"Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation","volume":"267","author":"Lintion","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.134366_bib0365","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41591-018-0336-8","article-title":"ApoE attenuates unresolvable inflammation by complex formation with activated C1q","volume":"25","author":"Yin","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.neulet.2019.134366_bib0370","first-page":"65","article-title":"Alzheimer\u2019s disease neuroimagining initiative, The relationship between complement factor C3, APOE\u03b54, amyloid and tau in Alzheimer\u2019s disease","volume":"4","author":"Bonham","year":"2016","journal-title":"Acta Neuro. Comm."},{"key":"10.1016\/j.neulet.2019.134366_bib0375","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.134366_bib0380","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1172\/JCI112130","article-title":"Apolipoprotein E associated with astrocytic glia of the central nervous system and with non-mylinating glia of the peripheral nervous system","volume":"76","author":"Boyles","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2019.134366_bib0385","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","article-title":"CNS synaptogenesis promoted by glia-derived cholesterol","volume":"294","author":"Mauch","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.134366_bib0390","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1006\/nbdi.2001.0401","article-title":"Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion","volume":"8","author":"White","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2019.134366_bib0395","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1523\/JNEUROSCI.21-03-00812.2001","article-title":"Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain","volume":"21","author":"Grehan","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134366_bib0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194661","article-title":"Class I HDAC inhibition is a novel pathway for regulating astrocytic apoE secretion","volume":"13","author":"Dresselhaus","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2019.134366_bib0405","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1194\/jlr.M081851","article-title":"Small molecule inducers of ABCA1 and apoE that act through indirect activation of the LXR pathway","volume":"59","author":"Fan","year":"2018","journal-title":"J. Lip. Res."},{"key":"10.1016\/j.neulet.2019.134366_bib0410","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-016-0173-2","article-title":"Double-blind, placebo controlled, proof-of-concept trial of bexarotene in moderate Alzheimer\u2019s disease","volume":"8","author":"Cummings","year":"2016","journal-title":"Alz Res. Ther."},{"key":"10.1016\/j.neulet.2019.134366_bib0415","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00005072-199703000-00007","article-title":"Glia-neuronal interactions in Alzheimer disease: progressive association of IL-1 alpha + microglia and s100beta+ astrocytes with neurofibrillary tangle stages","volume":"56","author":"Sheng","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neulet.2019.134366_bib0420","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41586-019-0924-x","article-title":"Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution","volume":"566","author":"Masuda","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.134366_bib0425","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1073\/pnas.0914984107","article-title":"ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling","volume":"107","author":"Chen","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2019.134366_bib0430","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.40048","article-title":"Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer\u2019s disease","volume":"7","author":"Xian","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.neulet.2019.134366_bib0435","first-page":"E6640","article-title":"Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH","volume":"115","author":"Prasd","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2019.134366_bib0440","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","article-title":"Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer\u2019s disease","volume":"16","author":"Gmez-Isla","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134366_bib0445","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.2635903100","article-title":"Functional brain abnormalities in young adults at genetic risk for late -onset Alzheimer\u2019s dementia","volume":"101","author":"Reiman","year":"2004","journal-title":"Proc. Natl. Acad. Sc.i"},{"key":"10.1016\/j.neulet.2019.134366_bib0450","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1073\/pnas.0811879106","article-title":"Distinct patterns of brain activity in young carriers of the APOE-\u03b54 allele","volume":"106","author":"Filippini","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2019.134366_bib0455","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1523\/JNEUROSCI.4026-09.2009","article-title":"ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo","volume":"29","author":"Dumanis","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134366_bib0460","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neuroscience.2003.08.007","article-title":"Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer\u2019s disease patients","volume":"122","author":"Ji","year":"2003","journal-title":"Neurosci."},{"key":"10.1016\/j.neulet.2019.134366_bib0465","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41419-018-0465-5","article-title":"Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein E","volume":"9","author":"Zheng","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neulet.2019.134366_bib0470","first-page":"699","article-title":"Association of cancer history with Alzheimer\u2019s disease dementia and neuropathology","volume":"56","author":"Yarchoan","year":"2017","journal-title":"J. Alz. Dis."},{"key":"10.1016\/j.neulet.2019.134366_bib0475","doi-asserted-by":"crossref","first-page":"13568","DOI":"10.1523\/JNEUROSCI.2468-15.2015","article-title":"APOE isoforms control pathogenic subretinal inflammation in age-related macular degeneration","volume":"35","author":"Levy","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134366_bib0480","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","article-title":"Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of \u03b2-amyloidosis","volume":"96","author":"Huynh","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.134366_bib0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019304690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019304690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:29:27Z","timestamp":1759609767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394019304690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":97,"alternative-id":["S0304394019304690"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2019.134366","relation":{},"ISSN":["0304-3940"],"issn-type":[{"type":"print","value":"0304-3940"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting apolipoprotein E for treating Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2019.134366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"134366"}}